APA (7th ed.) Citation

WJ, M., AS, H., JTJ, H., AN, S., JJ, H., S, W., . . . C, L. (2021). Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study. Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 42(7), e849. https://doi.org/10.1097/MAO.0000000000003120

Chicago Style (17th ed.) Citation

WJ, McLean, et al. "Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study." Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology 42, no. 7 (2021): e849. https://doi.org/10.1097/MAO.0000000000003120.

MLA (9th ed.) Citation

WJ, McLean, et al. "Improved Speech Intelligibility in Subjects With Stable Sensorineural Hearing Loss Following Intratympanic Dosing of FX-322 in a Phase 1b Study." Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, vol. 42, no. 7, 2021, p. e849, https://doi.org/10.1097/MAO.0000000000003120.